Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.70499048 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.70499048 |
3 | modulation by symbiont of host immune response (GO:0052553) | 6.70499048 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.70499048 |
5 | modulation by symbiont of host defense response (GO:0052031) | 6.70499048 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.70499048 |
7 | neutrophil activation involved in immune response (GO:0002283) | 6.36076843 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.69247123 |
9 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.24952535 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.18448313 |
11 | macrophage activation involved in immune response (GO:0002281) | 5.14716278 |
12 | negative regulation of interleukin-12 production (GO:0032695) | 4.71453413 |
13 | natural killer cell mediated immunity (GO:0002228) | 4.66175828 |
14 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.66175828 |
15 | immunoglobulin mediated immune response (GO:0016064) | 4.37468759 |
16 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.34293178 |
17 | positive regulation of interferon-alpha production (GO:0032727) | 4.32886752 |
18 | response to peptidoglycan (GO:0032494) | 4.32627632 |
19 | granulocyte activation (GO:0036230) | 4.22614061 |
20 | response to host immune response (GO:0052572) | 4.13232165 |
21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.13232165 |
22 | neutrophil activation (GO:0042119) | 4.12121109 |
23 | respiratory burst (GO:0045730) | 4.10257819 |
24 | regulation of interferon-alpha production (GO:0032647) | 4.08227221 |
25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.08214380 |
26 | regulation of vitamin metabolic process (GO:0030656) | 4.02658697 |
27 | T-helper 1 type immune response (GO:0042088) | 3.97687366 |
28 | microglial cell activation (GO:0001774) | 3.92341192 |
29 | superoxide anion generation (GO:0042554) | 3.73536274 |
30 | response to host (GO:0075136) | 3.68292995 |
31 | response to host defenses (GO:0052200) | 3.68292995 |
32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.68292995 |
33 | positive regulation of interferon-beta production (GO:0032728) | 3.66946566 |
34 | regulation of chronic inflammatory response (GO:0002676) | 3.64612217 |
35 | macrophage activation (GO:0042116) | 3.63341151 |
36 | myeloid cell activation involved in immune response (GO:0002275) | 3.61475645 |
37 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.55714254 |
38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.54911515 |
39 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.54086145 |
40 | phagosome maturation (GO:0090382) | 3.53186666 |
41 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.51777197 |
42 | glycosphingolipid catabolic process (GO:0046479) | 3.50527579 |
43 | oligosaccharide catabolic process (GO:0009313) | 3.50108043 |
44 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.49635209 |
45 | leukocyte mediated cytotoxicity (GO:0001909) | 3.43484606 |
46 | negative regulation of mast cell activation (GO:0033004) | 3.40515188 |
47 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.39772890 |
48 | regulation of mononuclear cell migration (GO:0071675) | 3.38822330 |
49 | response to muramyl dipeptide (GO:0032495) | 3.37759742 |
50 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.36486934 |
51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.36173411 |
52 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.33977569 |
53 | positive regulation of mast cell activation (GO:0033005) | 3.33217717 |
54 | regulation of mast cell degranulation (GO:0043304) | 3.32832135 |
55 | regulation of interleukin-12 production (GO:0032655) | 3.31935158 |
56 | regulation of chemokine biosynthetic process (GO:0045073) | 3.30517427 |
57 | melanin biosynthetic process (GO:0042438) | 3.30229795 |
58 | defense response to protozoan (GO:0042832) | 3.29026487 |
59 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.28681676 |
60 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.26859529 |
61 | positive regulation of mast cell degranulation (GO:0043306) | 3.24326075 |
62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.24326075 |
63 | B cell mediated immunity (GO:0019724) | 3.22609577 |
64 | positive regulation of leukocyte degranulation (GO:0043302) | 3.21239810 |
65 | myeloid dendritic cell activation (GO:0001773) | 3.18151758 |
66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17490974 |
67 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.17188277 |
68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15880988 |
69 | dendritic cell differentiation (GO:0097028) | 3.15155741 |
70 | glycolipid catabolic process (GO:0019377) | 3.15105306 |
71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14889537 |
72 | negative regulation of lipid storage (GO:0010888) | 3.14888657 |
73 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.14647673 |
74 | response to protozoan (GO:0001562) | 3.14204530 |
75 | wound healing, spreading of epidermal cells (GO:0035313) | 3.10909029 |
76 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.10660534 |
77 | folic acid transport (GO:0015884) | 3.10115478 |
78 | positive regulation of heat generation (GO:0031652) | 3.06674816 |
79 | positive regulation of osteoclast differentiation (GO:0045672) | 3.06556364 |
80 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.04336410 |
81 | amino sugar catabolic process (GO:0046348) | 3.03897623 |
82 | regulation of mast cell activation (GO:0033003) | 3.03497075 |
83 | positive regulation of interleukin-12 production (GO:0032735) | 3.02351743 |
84 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.02209791 |
85 | positive regulation of type 2 immune response (GO:0002830) | 3.02134176 |
86 | lymphocyte mediated immunity (GO:0002449) | 3.00717669 |
87 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.00492831 |
88 | response to thyroid hormone (GO:0097066) | 2.98805108 |
89 | endosome to pigment granule transport (GO:0043485) | 2.97184315 |
90 | endosome to melanosome transport (GO:0035646) | 2.97184315 |
91 | virion attachment to host cell (GO:0019062) | 2.96530616 |
92 | adhesion of symbiont to host cell (GO:0044650) | 2.96530616 |
93 | NIK/NF-kappaB signaling (GO:0038061) | 2.94136788 |
94 | regulation of cholesterol storage (GO:0010885) | 2.93209066 |
95 | germinal center formation (GO:0002467) | 2.93171626 |
96 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.92538742 |
97 | regulation of immunoglobulin secretion (GO:0051023) | 2.92107015 |
98 | detection of molecule of bacterial origin (GO:0032490) | 2.90896645 |
99 | regulation of antigen processing and presentation (GO:0002577) | 2.90734538 |
100 | regulation of podosome assembly (GO:0071801) | 2.90682532 |
101 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.90339036 |
102 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.90013119 |
103 | regulation of interferon-beta production (GO:0032648) | 2.89835689 |
104 | type I interferon signaling pathway (GO:0060337) | 2.89073835 |
105 | cellular response to type I interferon (GO:0071357) | 2.89073835 |
106 | response to lipoprotein particle (GO:0055094) | 2.88497797 |
107 | reactive oxygen species biosynthetic process (GO:1903409) | 2.88130963 |
108 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.87686903 |
109 | regulation of T-helper cell differentiation (GO:0045622) | 2.87612251 |
110 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.86634434 |
111 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84833984 |
112 | regulation of heat generation (GO:0031650) | 2.83030221 |
113 | response to type I interferon (GO:0034340) | 2.82424666 |
114 | neutrophil mediated immunity (GO:0002446) | 2.81656563 |
115 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.81555636 |
116 | regulation of RIG-I signaling pathway (GO:0039535) | 2.81151048 |
117 | regulation of integrin activation (GO:0033623) | 2.80835758 |
118 | eosinophil chemotaxis (GO:0048245) | 2.80790711 |
119 | cellular response to lipopolysaccharide (GO:0071222) | 2.80759325 |
120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.80496184 |
121 | positive regulation of T cell apoptotic process (GO:0070234) | 2.80344173 |
122 | ceramide catabolic process (GO:0046514) | 2.79089822 |
123 | autophagic vacuole fusion (GO:0000046) | 2.77157789 |
124 | regulation of leukocyte degranulation (GO:0043300) | 2.76456494 |
125 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.76020670 |
126 | negative regulation of interleukin-17 production (GO:0032700) | 2.75162713 |
127 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74636729 |
128 | melanin metabolic process (GO:0006582) | 2.74574267 |
129 | cellular response to molecule of bacterial origin (GO:0071219) | 2.72876239 |
130 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.71940960 |
131 | myeloid leukocyte activation (GO:0002274) | 2.70982157 |
132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70143826 |
133 | intracellular pH reduction (GO:0051452) | 2.69879413 |
134 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.69464086 |
135 | positive regulation of interleukin-10 production (GO:0032733) | 2.68878843 |
136 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.68071395 |
137 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.68071395 |
138 | T cell differentiation involved in immune response (GO:0002292) | 2.68071395 |
139 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.68069292 |
140 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.67830950 |
141 | regulation of T cell tolerance induction (GO:0002664) | 2.67347006 |
142 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.67341963 |
143 | I-kappaB phosphorylation (GO:0007252) | 2.66140083 |
144 | secondary metabolite biosynthetic process (GO:0044550) | 2.65891593 |
145 | negative regulation of growth of symbiont in host (GO:0044130) | 2.64294949 |
146 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.64294949 |
147 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.64294949 |
148 | regulation of growth of symbiont in host (GO:0044126) | 2.64294949 |
149 | regulation of fever generation (GO:0031620) | 2.63498278 |
150 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.63320307 |
151 | regulation of early endosome to late endosome transport (GO:2000641) | 2.62726872 |
152 | regulation of macrophage chemotaxis (GO:0010758) | 2.62685071 |
153 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.62666492 |
154 | T-helper cell differentiation (GO:0042093) | 2.62666492 |
155 | pinocytosis (GO:0006907) | 2.61887485 |
156 | cellular response to interferon-gamma (GO:0071346) | 2.59715836 |
157 | monocyte chemotaxis (GO:0002548) | 2.58017535 |
158 | cell adhesion mediated by integrin (GO:0033627) | 2.57805538 |
159 | N-acetylneuraminate metabolic process (GO:0006054) | 2.57058286 |
160 | myeloid dendritic cell differentiation (GO:0043011) | 2.56920598 |
161 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.56917539 |
162 | membrane lipid catabolic process (GO:0046466) | 2.56484140 |
163 | T cell activation involved in immune response (GO:0002286) | 2.56008589 |
164 | sphingosine metabolic process (GO:0006670) | 2.55720235 |
165 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.55704352 |
166 | positive regulation of interleukin-6 production (GO:0032755) | 2.54410434 |
167 | regulation of type 2 immune response (GO:0002828) | 2.53037421 |
168 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.52722650 |
169 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.51470450 |
170 | adhesion of symbiont to host (GO:0044406) | 2.50451843 |
171 | response to interferon-gamma (GO:0034341) | 2.49977144 |
172 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.49872635 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.54071923 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.47330611 |
3 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.21778485 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.12263174 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.06537344 |
6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54485783 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.46656645 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.43097783 |
9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95430316 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76563122 |
11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.63665890 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55982390 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.51998498 |
14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.37762338 |
15 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.27066290 |
16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.22506505 |
17 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.21564715 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21007900 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15956947 |
20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03824583 |
21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02503852 |
22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01173831 |
23 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87827892 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75668594 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75564234 |
26 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69706563 |
27 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67569925 |
28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65593572 |
29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64992238 |
30 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.64468746 |
31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63771134 |
32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58581910 |
33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55622560 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55525038 |
35 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.54769825 |
36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48225679 |
37 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46953211 |
38 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45601413 |
39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45226432 |
40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44997698 |
41 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42441524 |
42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40494792 |
43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38372415 |
44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38286097 |
45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36393051 |
46 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35910111 |
47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32363959 |
48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31899872 |
49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31396333 |
50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30522625 |
51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25731247 |
52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25283610 |
53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24920544 |
54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21505605 |
55 | MYB_26560356_Chip-Seq_TH2_Human | 1.19122630 |
56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18854180 |
57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17177051 |
58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16371781 |
59 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15611741 |
60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13351696 |
61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12318514 |
62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12087578 |
63 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11806897 |
64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11455475 |
65 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.10229603 |
66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09598528 |
67 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09378127 |
68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07204302 |
69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07079567 |
70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06438360 |
71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05337459 |
72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05337459 |
73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04242926 |
74 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04101633 |
75 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04101633 |
76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03892574 |
77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02747798 |
78 | MYB_26560356_Chip-Seq_TH1_Human | 1.02081186 |
79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02076316 |
80 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97427458 |
81 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97024334 |
82 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96453606 |
83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96017470 |
84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95696653 |
85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94617414 |
86 | MAF_26560356_Chip-Seq_TH1_Human | 0.93647563 |
87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93498998 |
88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93318474 |
89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92472993 |
90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92098837 |
91 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.91070291 |
92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91003887 |
93 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89710609 |
94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89198156 |
95 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.88550852 |
96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87681759 |
97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87420724 |
98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86983755 |
99 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.86737147 |
100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86647094 |
101 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86361279 |
102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85567364 |
103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85339183 |
104 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85078090 |
105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83949781 |
106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.83895083 |
107 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83152570 |
108 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82928727 |
109 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82647003 |
110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82352754 |
111 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.81763206 |
112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80498327 |
113 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80120781 |
114 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.79958946 |
115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.79507377 |
116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79339174 |
117 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.79242692 |
118 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79202641 |
119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78559434 |
120 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78469407 |
121 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.76141451 |
122 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75855882 |
123 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.75010493 |
124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74716852 |
125 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.74289362 |
126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73315082 |
127 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.72893144 |
128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72439925 |
129 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.71770016 |
130 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71400269 |
131 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.70581248 |
132 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.70400902 |
133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.68805735 |
134 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.67761624 |
135 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.67297168 |
136 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.67259106 |
137 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.66944854 |
138 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.66880722 |
139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66032844 |
140 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.65921293 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 5.10703161 |
2 | MP0001835_abnormal_antigen_presentation | 3.29816415 |
3 | MP0008260_abnormal_autophagy | 3.25032568 |
4 | MP0000569_abnormal_digit_pigmentation | 3.19226436 |
5 | MP0006082_CNS_inflammation | 3.16679897 |
6 | MP0003172_abnormal_lysosome_physiology | 3.08746764 |
7 | MP0005257_abnormal_intraocular_pressure | 3.06025408 |
8 | MP0003436_decreased_susceptibility_to | 3.02599713 |
9 | MP0009840_abnormal_foam_cell | 2.91938059 |
10 | MP0002419_abnormal_innate_immunity | 2.72367552 |
11 | MP0002139_abnormal_hepatobiliary_system | 2.56703146 |
12 | MP0003303_peritoneal_inflammation | 2.45088891 |
13 | MP0004510_myositis | 2.39808347 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.39434948 |
15 | MP0005000_abnormal_immune_tolerance | 2.38317986 |
16 | MP0000372_irregular_coat_pigmentation | 2.20753360 |
17 | MP0009785_altered_susceptibility_to | 2.11730984 |
18 | MP0002452_abnormal_antigen_presenting | 2.11231247 |
19 | MP0005167_abnormal_blood-brain_barrier | 2.04138922 |
20 | MP0005387_immune_system_phenotype | 2.03083517 |
21 | MP0001790_abnormal_immune_system | 2.03083517 |
22 | MP0003191_abnormal_cellular_cholesterol | 1.97549137 |
23 | MP0005025_abnormal_response_to | 1.92012544 |
24 | MP0005310_abnormal_salivary_gland | 1.86309931 |
25 | MP0002723_abnormal_immune_serum | 1.84042589 |
26 | MP0000371_diluted_coat_color | 1.83963967 |
27 | MP0002254_reproductive_system_inflammat | 1.83659085 |
28 | MP0003448_altered_tumor_morphology | 1.81980700 |
29 | MP0001533_abnormal_skeleton_physiology | 1.73880597 |
30 | MP0001819_abnormal_immune_cell | 1.65453504 |
31 | MP0001800_abnormal_humoral_immune | 1.65181421 |
32 | MP0000685_abnormal_immune_system | 1.63447862 |
33 | MP0002998_abnormal_bone_remodeling | 1.63179942 |
34 | MP0002420_abnormal_adaptive_immunity | 1.61340751 |
35 | MP0004947_skin_inflammation | 1.59019141 |
36 | MP0001958_emphysema | 1.57414501 |
37 | MP0010307_abnormal_tumor_latency | 1.54557762 |
38 | MP0003183_abnormal_peptide_metabolism | 1.52873402 |
39 | MP0005171_absent_coat_pigmentation | 1.52781140 |
40 | MP0000604_amyloidosis | 1.50771271 |
41 | MP0005464_abnormal_platelet_physiology | 1.50390125 |
42 | MP0000015_abnormal_ear_pigmentation | 1.48098044 |
43 | MP0009278_abnormal_bone_marrow | 1.47480070 |
44 | MP0008004_abnormal_stomach_pH | 1.46981188 |
45 | MP0009333_abnormal_splenocyte_physiolog | 1.46643511 |
46 | MP0000920_abnormal_myelination | 1.39206004 |
47 | MP0005174_abnormal_tail_pigmentation | 1.38636868 |
48 | MP0001845_abnormal_inflammatory_respons | 1.38431143 |
49 | MP0005671_abnormal_response_to | 1.38094681 |
50 | MP0002405_respiratory_system_inflammati | 1.37692694 |
51 | MP0003724_increased_susceptibility_to | 1.37305366 |
52 | MP0003693_abnormal_embryo_hatching | 1.35083470 |
53 | MP0003195_calcinosis | 1.33319486 |
54 | MP0005408_hypopigmentation | 1.33241414 |
55 | MP0003690_abnormal_glial_cell | 1.29563709 |
56 | MP0002877_abnormal_melanocyte_morpholog | 1.26585630 |
57 | MP0000858_altered_metastatic_potential | 1.25627167 |
58 | MP0000343_altered_response_to | 1.22475759 |
59 | MP0008469_abnormal_protein_level | 1.22278936 |
60 | MP0004782_abnormal_surfactant_physiolog | 1.19496157 |
61 | MP0003566_abnormal_cell_adhesion | 1.18251746 |
62 | MP0001853_heart_inflammation | 1.15507074 |
63 | MP0006054_spinal_hemorrhage | 1.13025638 |
64 | MP0002837_dystrophic_cardiac_calcinosis | 1.11599365 |
65 | MP0000716_abnormal_immune_system | 1.09602041 |
66 | MP0003186_abnormal_redox_activity | 1.09458637 |
67 | MP0003329_amyloid_beta_deposits | 1.07783865 |
68 | MP0005397_hematopoietic_system_phenotyp | 1.07391858 |
69 | MP0001545_abnormal_hematopoietic_system | 1.07391858 |
70 | MP0004858_abnormal_nervous_system | 1.02239708 |
71 | MP0001756_abnormal_urination | 1.02124395 |
72 | MP0001542_abnormal_bone_strength | 0.99664040 |
73 | MP0000689_abnormal_spleen_morphology | 0.98916858 |
74 | MP0008438_abnormal_cutaneous_collagen | 0.97616325 |
75 | MP0005390_skeleton_phenotype | 0.97613019 |
76 | MP0002136_abnormal_kidney_physiology | 0.96937048 |
77 | MP0002006_tumorigenesis | 0.95400287 |
78 | MP0009764_decreased_sensitivity_to | 0.94315948 |
79 | MP0002332_abnormal_exercise_endurance | 0.93919732 |
80 | MP0003075_altered_response_to | 0.93898677 |
81 | MP0003705_abnormal_hypodermis_morpholog | 0.93500082 |
82 | MP0005451_abnormal_body_composition | 0.92576446 |
83 | MP0003718_maternal_effect | 0.92374847 |
84 | MP0002398_abnormal_bone_marrow | 0.90957186 |
85 | MP0010386_abnormal_urinary_bladder | 0.90252297 |
86 | MP0005165_increased_susceptibility_to | 0.90063192 |
87 | MP0002138_abnormal_hepatobiliary_system | 0.89329518 |
88 | MP0003091_abnormal_cell_migration | 0.89001138 |
89 | MP0002163_abnormal_gland_morphology | 0.88874848 |
90 | MP0005164_abnormal_response_to | 0.88671379 |
91 | MP0002429_abnormal_blood_cell | 0.88622285 |
92 | MP0005166_decreased_susceptibility_to | 0.86959280 |
93 | MP0003795_abnormal_bone_structure | 0.86718358 |
94 | MP0003806_abnormal_nucleotide_metabolis | 0.85903610 |
95 | MP0005076_abnormal_cell_differentiation | 0.82610231 |
96 | MP0001501_abnormal_sleep_pattern | 0.80943003 |
97 | MP0005647_abnormal_sex_gland | 0.80830980 |
98 | MP0002722_abnormal_immune_system | 0.80424875 |
99 | MP0005197_abnormal_uvea_morphology | 0.79562734 |
100 | MP0002277_abnormal_respiratory_mucosa | 0.79268081 |
101 | MP0003828_pulmonary_edema | 0.78576336 |
102 | MP0010155_abnormal_intestine_physiology | 0.76866913 |
103 | MP0003656_abnormal_erythrocyte_physiolo | 0.76343110 |
104 | MP0002075_abnormal_coat/hair_pigmentati | 0.76188346 |
105 | MP0003633_abnormal_nervous_system | 0.75858420 |
106 | MP0003453_abnormal_keratinocyte_physiol | 0.75238840 |
107 | MP0003300_gastrointestinal_ulcer | 0.74964405 |
108 | MP0002095_abnormal_skin_pigmentation | 0.74538039 |
109 | MP0005621_abnormal_cell_physiology | 0.73952671 |
110 | MP0003136_yellow_coat_color | 0.73638919 |
111 | MP0003634_abnormal_glial_cell | 0.73489222 |
112 | MP0009763_increased_sensitivity_to | 0.73248730 |
113 | MP0003279_aneurysm | 0.72856537 |
114 | MP0001873_stomach_inflammation | 0.72845454 |
115 | MP0002933_joint_inflammation | 0.72201514 |
116 | MP0005395_other_phenotype | 0.72194131 |
117 | MP0000465_gastrointestinal_hemorrhage | 0.72033941 |
118 | MP0002090_abnormal_vision | 0.70143342 |
119 | MP0004381_abnormal_hair_follicle | 0.69416851 |
120 | MP0001663_abnormal_digestive_system | 0.68903372 |
121 | MP0008874_decreased_physiological_sensi | 0.68635184 |
122 | MP0009765_abnormal_xenobiotic_induced | 0.68190754 |
123 | MP0005075_abnormal_melanosome_morpholog | 0.67560045 |
124 | MP0005379_endocrine/exocrine_gland_phen | 0.66431330 |
125 | MP0005595_abnormal_vascular_smooth | 0.63469527 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.66244458 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.09853888 |
3 | Increased cerebral lipofuscin (HP:0011813) | 5.91016525 |
4 | Abnormality of macrophages (HP:0004311) | 5.61928224 |
5 | Vacuolated lymphocytes (HP:0001922) | 5.59962023 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.47393604 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.47393604 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.47393604 |
9 | Eczematoid dermatitis (HP:0000976) | 5.30408721 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.24043776 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.59012643 |
12 | Dysostosis multiplex (HP:0000943) | 4.49523251 |
13 | Axonal loss (HP:0003447) | 4.21500014 |
14 | Autoimmune thrombocytopenia (HP:0001973) | 4.02552015 |
15 | Neurofibrillary tangles (HP:0002185) | 3.97553331 |
16 | Disinhibition (HP:0000734) | 3.81882651 |
17 | Mucopolysacchariduria (HP:0008155) | 3.72211830 |
18 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.72211830 |
19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.65332821 |
20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.59586699 |
21 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.59586699 |
22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.59586699 |
23 | Gingivitis (HP:0000230) | 3.58517860 |
24 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.55218490 |
25 | Nuclear cataract (HP:0100018) | 3.41663056 |
26 | Pustule (HP:0200039) | 3.41627949 |
27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.31150291 |
28 | Obstructive lung disease (HP:0006536) | 3.31150291 |
29 | Mediastinal lymphadenopathy (HP:0100721) | 3.26500139 |
30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.23575452 |
31 | Recurrent skin infections (HP:0001581) | 3.12543420 |
32 | Purpura (HP:0000979) | 2.97397948 |
33 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.89957821 |
34 | Osteolytic defects of the hand bones (HP:0009699) | 2.89957821 |
35 | Thick nail (HP:0001805) | 2.89649118 |
36 | Systemic lupus erythematosus (HP:0002725) | 2.86916671 |
37 | Cerebral inclusion bodies (HP:0100314) | 2.79925034 |
38 | Myositis (HP:0100614) | 2.75068676 |
39 | Prostate neoplasm (HP:0100787) | 2.70910282 |
40 | Myocardial infarction (HP:0001658) | 2.69273720 |
41 | Basal ganglia calcification (HP:0002135) | 2.68459130 |
42 | Personality changes (HP:0000751) | 2.66375714 |
43 | Recurrent fungal infections (HP:0002841) | 2.65782969 |
44 | Loss of speech (HP:0002371) | 2.65781922 |
45 | Prolonged neonatal jaundice (HP:0006579) | 2.64936661 |
46 | Orchitis (HP:0100796) | 2.62959291 |
47 | Hepatosplenomegaly (HP:0001433) | 2.58457874 |
48 | Interstitial pulmonary disease (HP:0006530) | 2.57998117 |
49 | Poor head control (HP:0002421) | 2.50695477 |
50 | Agnosia (HP:0010524) | 2.50448052 |
51 | Neuronal loss in central nervous system (HP:0002529) | 2.47754682 |
52 | Metaphyseal irregularity (HP:0003025) | 2.47042521 |
53 | Optic neuritis (HP:0100653) | 2.46682641 |
54 | Retrobulbar optic neuritis (HP:0100654) | 2.46682641 |
55 | Peripheral demyelination (HP:0011096) | 2.44214248 |
56 | Vertebral compression fractures (HP:0002953) | 2.43745742 |
57 | Premature loss of primary teeth (HP:0006323) | 2.39273851 |
58 | Periodontitis (HP:0000704) | 2.36626100 |
59 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.36146720 |
60 | Stomatitis (HP:0010280) | 2.35895289 |
61 | Hemoptysis (HP:0002105) | 2.35115888 |
62 | Progressive visual loss (HP:0000529) | 2.31979720 |
63 | Keratoconjunctivitis sicca (HP:0001097) | 2.30989437 |
64 | Pathologic fracture (HP:0002756) | 2.28760067 |
65 | Supranuclear gaze palsy (HP:0000605) | 2.26396381 |
66 | Complement deficiency (HP:0004431) | 2.24323403 |
67 | Ocular albinism (HP:0001107) | 2.19449661 |
68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19110104 |
69 | Inappropriate behavior (HP:0000719) | 2.19070634 |
70 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.17519932 |
71 | Diminished motivation (HP:0000745) | 2.17412060 |
72 | Upper motor neuron abnormality (HP:0002127) | 2.17068512 |
73 | Hematochezia (HP:0002573) | 2.16144907 |
74 | Dementia (HP:0000726) | 2.15370510 |
75 | Nausea (HP:0002018) | 2.14131128 |
76 | Gangrene (HP:0100758) | 2.14006943 |
77 | Cervical subluxation (HP:0003308) | 2.13395506 |
78 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.12879094 |
79 | Keratoconjunctivitis (HP:0001096) | 2.12775828 |
80 | Increased IgM level (HP:0003496) | 2.12222031 |
81 | Tetraparesis (HP:0002273) | 2.11558126 |
82 | Polyneuropathy (HP:0001271) | 2.11020356 |
83 | Apathy (HP:0000741) | 2.08588745 |
84 | Amyloidosis (HP:0011034) | 2.08176771 |
85 | Recurrent pneumonia (HP:0006532) | 2.07064154 |
86 | Short nail (HP:0001799) | 2.05464687 |
87 | Conjunctival telangiectasia (HP:0000524) | 2.03101778 |
88 | J-shaped sella turcica (HP:0002680) | 2.02635062 |
89 | Bone pain (HP:0002653) | 2.02539972 |
90 | Vasculitis (HP:0002633) | 2.02524680 |
91 | Submucous cleft hard palate (HP:0000176) | 2.01895228 |
92 | Cellulitis (HP:0100658) | 2.01421922 |
93 | T lymphocytopenia (HP:0005403) | 1.99480863 |
94 | Hypoplasia of the fovea (HP:0007750) | 1.98885301 |
95 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.98885301 |
96 | Increased serum ferritin (HP:0003281) | 1.94509168 |
97 | Osteomyelitis (HP:0002754) | 1.92297114 |
98 | Abnormality of the periventricular white matter (HP:0002518) | 1.91710268 |
99 | Urticaria (HP:0001025) | 1.91212235 |
100 | Spinal muscular atrophy (HP:0007269) | 1.89515706 |
101 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.88557059 |
102 | Glomerulonephritis (HP:0000099) | 1.88385402 |
103 | Premature rupture of membranes (HP:0001788) | 1.88008722 |
104 | Gastrointestinal stroma tumor (HP:0100723) | 1.87267944 |
105 | Malnutrition (HP:0004395) | 1.85713150 |
106 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.85027852 |
107 | Progressive neurologic deterioration (HP:0002344) | 1.84831940 |
108 | Recurrent viral infections (HP:0004429) | 1.84252206 |
109 | Juvenile onset (HP:0003621) | 1.82491192 |
110 | Albinism (HP:0001022) | 1.81903707 |
111 | Mutism (HP:0002300) | 1.81598245 |
112 | Spontaneous hematomas (HP:0007420) | 1.81524092 |
113 | Eosinophilia (HP:0001880) | 1.81064947 |
114 | Global brain atrophy (HP:0002283) | 1.79990299 |
115 | Cardiomegaly (HP:0001640) | 1.79537891 |
116 | Leukocytosis (HP:0001974) | 1.79205437 |
117 | Joint swelling (HP:0001386) | 1.76159236 |
118 | Cheilitis (HP:0100825) | 1.76063891 |
119 | Abnormality of T cell number (HP:0011839) | 1.75943514 |
120 | Memory impairment (HP:0002354) | 1.75403003 |
121 | Restrictive lung disease (HP:0002091) | 1.75076553 |
122 | Mesangial abnormality (HP:0001966) | 1.74515899 |
123 | Anorexia (HP:0002039) | 1.74176581 |
124 | Iris hypopigmentation (HP:0007730) | 1.72734736 |
125 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.72397527 |
126 | Increased CSF protein (HP:0002922) | 1.72249799 |
127 | Abnormality of the fovea (HP:0000493) | 1.71691285 |
128 | Hypergammaglobulinemia (HP:0010702) | 1.69717509 |
129 | Abnormality of the basal ganglia (HP:0002134) | 1.68579855 |
130 | Petechiae (HP:0000967) | 1.67164505 |
131 | Pulmonary infiltrates (HP:0002113) | 1.67072785 |
132 | Tetany (HP:0001281) | 1.65916237 |
133 | Neurodegeneration (HP:0002180) | 1.63156953 |
134 | Asymmetric septal hypertrophy (HP:0001670) | 1.63085364 |
135 | Protuberant abdomen (HP:0001538) | 1.59696295 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK3 | 3.73005965 |
2 | RIPK4 | 3.72405242 |
3 | GRK7 | 3.50257425 |
4 | MAP3K14 | 3.48704669 |
5 | TBK1 | 3.25231926 |
6 | IRAK4 | 3.05364048 |
7 | DDR2 | 3.04726930 |
8 | NME2 | 2.79495845 |
9 | BUB1 | 2.78168563 |
10 | PBK | 2.72492960 |
11 | TYK2 | 2.33033370 |
12 | BLK | 2.31462516 |
13 | MST1R | 2.31401339 |
14 | PIM2 | 2.18747879 |
15 | KIT | 2.11171861 |
16 | EPHA2 | 2.03859465 |
17 | IKBKB | 2.02593088 |
18 | ADRBK2 | 1.96213250 |
19 | ARAF | 1.92664593 |
20 | NEK9 | 1.91241469 |
21 | MARK3 | 1.84174284 |
22 | RPS6KA4 | 1.72315364 |
23 | MAP4K1 | 1.59824313 |
24 | PLK4 | 1.57618715 |
25 | TAOK1 | 1.54911653 |
26 | ERN1 | 1.41172680 |
27 | CDC42BPA | 1.40707985 |
28 | CHUK | 1.39139764 |
29 | TGFBR2 | 1.39061389 |
30 | WEE1 | 1.36825195 |
31 | IKBKE | 1.36493214 |
32 | JAK3 | 1.27634514 |
33 | ABL2 | 1.26938341 |
34 | STK3 | 1.22521925 |
35 | JAK1 | 1.22438176 |
36 | PIM1 | 1.17757443 |
37 | MAP3K3 | 1.17741023 |
38 | ZAP70 | 1.15894205 |
39 | PRPF4B | 1.14919596 |
40 | MAP3K13 | 1.12220622 |
41 | TNK2 | 1.10537763 |
42 | CAMKK2 | 1.08838678 |
43 | FGR | 1.07868788 |
44 | BMX | 1.06808263 |
45 | TYRO3 | 1.05080795 |
46 | NEK2 | 1.01496929 |
47 | CSK | 1.01267295 |
48 | EPHB1 | 1.00552679 |
49 | ZAK | 0.99692948 |
50 | MAP3K1 | 0.99648080 |
51 | TRIB3 | 0.97721706 |
52 | PDK2 | 0.96866613 |
53 | HCK | 0.96514107 |
54 | PAK4 | 0.96461293 |
55 | CSF1R | 0.94540257 |
56 | ERBB3 | 0.93164775 |
57 | STK10 | 0.90750328 |
58 | STK24 | 0.87098897 |
59 | SCYL2 | 0.85554650 |
60 | MET | 0.83466533 |
61 | MST4 | 0.82995815 |
62 | MAP3K10 | 0.81917119 |
63 | DAPK2 | 0.81519810 |
64 | SYK | 0.81114786 |
65 | LYN | 0.79525024 |
66 | KSR2 | 0.78556321 |
67 | TAOK3 | 0.76909131 |
68 | PRKCD | 0.75085630 |
69 | IRAK1 | 0.75008384 |
70 | MOS | 0.74071864 |
71 | FRK | 0.71122516 |
72 | PKN1 | 0.69990971 |
73 | MAP2K6 | 0.69046218 |
74 | CAMK1D | 0.68326763 |
75 | STK4 | 0.68285430 |
76 | IRAK2 | 0.67768279 |
77 | ABL1 | 0.67656179 |
78 | PRKD3 | 0.65682097 |
79 | FER | 0.65205932 |
80 | MAP3K9 | 0.64003881 |
81 | PDGFRA | 0.62479356 |
82 | BRAF | 0.61771585 |
83 | TRPM7 | 0.61277889 |
84 | WNK3 | 0.60504823 |
85 | STK38L | 0.59251862 |
86 | MAP3K5 | 0.59022029 |
87 | MAP3K11 | 0.58412864 |
88 | BCR | 0.58342686 |
89 | LRRK2 | 0.57518572 |
90 | BRSK2 | 0.57420412 |
91 | MATK | 0.57217730 |
92 | PDK1 | 0.57128034 |
93 | CLK1 | 0.56534569 |
94 | JAK2 | 0.56523906 |
95 | PDGFRB | 0.56473796 |
96 | EPHA3 | 0.56417018 |
97 | MAP2K3 | 0.55485868 |
98 | MAPKAPK3 | 0.55287088 |
99 | TXK | 0.54724158 |
100 | BMPR2 | 0.54431620 |
101 | SIK3 | 0.54339573 |
102 | LCK | 0.52794208 |
103 | TAOK2 | 0.52624031 |
104 | EIF2AK3 | 0.51896426 |
105 | GSK3A | 0.50551492 |
106 | EGFR | 0.48560150 |
107 | CDK6 | 0.47993284 |
108 | MAPK7 | 0.47087255 |
109 | MAPKAPK2 | 0.46643793 |
110 | EIF2AK1 | 0.44960281 |
111 | CAMK2D | 0.44959034 |
112 | PDPK1 | 0.44307986 |
113 | TTN | 0.42344424 |
114 | EIF2AK2 | 0.42237360 |
115 | TGFBR1 | 0.41619260 |
116 | FES | 0.41392916 |
117 | ACVR1B | 0.40887753 |
118 | MAP3K8 | 0.40325021 |
119 | HIPK2 | 0.39835681 |
120 | AKT3 | 0.38220106 |
121 | SGK3 | 0.38103909 |
122 | MAP2K2 | 0.37909706 |
123 | PAK1 | 0.37901189 |
124 | PTK6 | 0.37610891 |
125 | CAMK2G | 0.36125971 |
126 | MAPK4 | 0.34422921 |
127 | TESK1 | 0.34007852 |
128 | CAMKK1 | 0.32970684 |
129 | INSR | 0.30312909 |
130 | SGK2 | 0.29991602 |
131 | PLK1 | 0.29460036 |
132 | FGFR3 | 0.28497326 |
133 | DYRK3 | 0.27859018 |
134 | ROCK2 | 0.27610459 |
135 | RIPK1 | 0.27040806 |
136 | CSNK1G3 | 0.26650850 |
137 | CSNK1G2 | 0.26149222 |
138 | PRKCQ | 0.24951854 |
139 | MAPK12 | 0.24500575 |
140 | CSNK1A1L | 0.24025463 |
141 | BTK | 0.23154424 |
142 | NTRK3 | 0.22823452 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Lysosome_Homo sapiens_hsa04142 | 3.85287185 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.92949517 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52395314 |
4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.45501312 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.36202979 |
6 | Phagosome_Homo sapiens_hsa04145 | 2.34962812 |
7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.31416984 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23368042 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.16415227 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14548753 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.08926803 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01590127 |
13 | Legionellosis_Homo sapiens_hsa05134 | 1.95829100 |
14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94287363 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.93773691 |
16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.86427255 |
17 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.86412188 |
18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83516852 |
19 | Malaria_Homo sapiens_hsa05144 | 1.69498439 |
20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66416011 |
21 | Apoptosis_Homo sapiens_hsa04210 | 1.61525540 |
22 | Pertussis_Homo sapiens_hsa05133 | 1.59539158 |
23 | Proteasome_Homo sapiens_hsa03050 | 1.56937505 |
24 | Measles_Homo sapiens_hsa05162 | 1.51157454 |
25 | Shigellosis_Homo sapiens_hsa05131 | 1.49475829 |
26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48464199 |
27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.46636017 |
28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.45739199 |
29 | Salmonella infection_Homo sapiens_hsa05132 | 1.39963976 |
30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39890784 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37991056 |
32 | Allograft rejection_Homo sapiens_hsa05330 | 1.37558568 |
33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.35555921 |
34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32461381 |
35 | Influenza A_Homo sapiens_hsa05164 | 1.32437095 |
36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28393570 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25420317 |
38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23427340 |
39 | Mineral absorption_Homo sapiens_hsa04978 | 1.09506425 |
40 | Asthma_Homo sapiens_hsa05310 | 1.07959052 |
41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04170364 |
42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01829771 |
43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01679846 |
44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01280813 |
45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99663669 |
46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98925855 |
47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97965174 |
48 | Hepatitis B_Homo sapiens_hsa05161 | 0.96741341 |
49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95753266 |
50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95638216 |
51 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93464878 |
52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93386977 |
53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91056407 |
54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90579432 |
55 | Hepatitis C_Homo sapiens_hsa05160 | 0.88797012 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87810214 |
57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84813063 |
58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82290116 |
59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81897765 |
60 | Endocytosis_Homo sapiens_hsa04144 | 0.81510924 |
61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79808992 |
62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79007093 |
63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78808884 |
64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.78200147 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77893442 |
66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76722016 |
67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71685756 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71429412 |
69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69089839 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68879380 |
71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68713865 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.67765155 |
73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67489236 |
74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62290107 |
75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61617984 |
76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60984949 |
77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60892049 |
78 | Bladder cancer_Homo sapiens_hsa05219 | 0.59421691 |
79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58493198 |
80 | RNA polymerase_Homo sapiens_hsa03020 | 0.57574665 |
81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57481706 |
82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57390626 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56778018 |
84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56445770 |
85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56372234 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56246714 |
87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56134461 |
88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51002578 |
89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50265592 |
90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49042806 |
91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48821599 |
92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48642616 |
93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47128287 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46927479 |
95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45979547 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44360982 |
97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44217067 |
98 | Prostate cancer_Homo sapiens_hsa05215 | 0.44000507 |
99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43879218 |
100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42915455 |
101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42890538 |
102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41919652 |
103 | Platelet activation_Homo sapiens_hsa04611 | 0.41756397 |
104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41001245 |
105 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38843804 |
106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38733811 |
107 | Prion diseases_Homo sapiens_hsa05020 | 0.36731605 |
108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36342885 |
109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36041274 |
110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35378582 |
111 | Cell cycle_Homo sapiens_hsa04110 | 0.33489855 |
112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32171300 |
113 | Adherens junction_Homo sapiens_hsa04520 | 0.31630839 |
114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30138717 |
115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29098344 |
116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25291661 |
117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25258644 |
118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25097600 |
119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24546868 |
120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20964936 |
121 | Insulin resistance_Homo sapiens_hsa04931 | 0.20921622 |
122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19758162 |
123 | Renin secretion_Homo sapiens_hsa04924 | 0.19009273 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18812808 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.16956874 |
126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14911812 |
127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.14249519 |